Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Leap Therapeutics, Inc.

Clinical trials sponsored by Leap Therapeutics, Inc., explained in plain language.

New drug combo tested in fight against advanced stomach cancer

Disease control Terminated

This study tested whether adding an experimental drug called DKN-01 to a standard immunotherapy (tislelizumab) and chemotherapy could better control advanced stomach or gastroesophageal cancer. It involved about 247 adults whose cancer could not be removed by surgery. The main go…

Phase: PHASE2 • Sponsor: Leap Therapeutics, Inc. • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC